GemVax&KAEL Co.Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.181x

GemVax&KAEL Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has a cash flow conversion efficiency ratio of 0.181x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.34 Billion ≈ $7.01 Million USD) by net assets (₩57.23 Billion ≈ $38.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of GemVax&KAEL Co.Ltd (2011–2025)

Cash flow conversion efficiency of GemVax&KAEL Co.Ltd from 2011 to 2025. This chart illustrates how GemVax&KAEL Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of GemVax&KAEL Co.Ltd for real-time trading data and today's change.

GemVax&KAEL Co.Ltd Cash Flow Conversion Ratio Explained

GemVax&KAEL Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

GemVax&KAEL Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their cash flow conversion efficiency. Also see 082270 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CHTC Helon Co Ltd SHE:000677	-0.004x
The Orissa Minerals Development Company Limited NSE:ORISSAMINE	0.738x
Shanghai Mechanical & Electrical Industry Co Ltd B SHG:900925	-0.013x
Mold-Tek Packaging Limited NSE:MOLDTKPAC	0.064x
Berkeley Energia Ltd AU:BKY	0.000x
Medallion Metals Ltd AU:MM8	-0.155x
AC Immune Ltd NASDAQ:ACIU	-0.522x
Hester Biosciences Limited NSE:HESTERBIO	0.050x

Annual Cash Flow Conversion Efficiency for GemVax&KAEL Co.Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of GemVax&KAEL Co.Ltd from 2011 to 2025. Review GemVax&KAEL Co.Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩57.23 Billion ≈ $38.78 Million	₩1.11 Billion ≈ $751.21K	0.019x	+101.98%
2024-12-31	₩29.01 Billion ≈ $19.66 Million	₩-28.37 Billion ≈ $-19.23 Million	-0.978x	-3062.96%
2023-12-31	₩108.02 Billion ≈ $73.20 Million	₩3.57 Billion ≈ $2.42 Million	0.033x	+250.07%
2022-12-31	₩134.35 Billion ≈ $91.05 Million	₩-2.96 Billion ≈ $-2.00 Million	-0.022x	+2.30%
2021-12-31	₩153.99 Billion ≈ $104.35 Million	₩-3.47 Billion ≈ $-2.35 Million	-0.023x	-121.81%
2020-12-31	₩135.21 Billion ≈ $91.63 Million	₩13.95 Billion ≈ $9.46 Million	0.103x	+1476.21%
2019-12-31	₩94.95 Billion ≈ $64.35 Million	₩-712.11 Million ≈ $-482.58K	-0.007x	-233.67%
2018-12-31	₩113.81 Billion ≈ $77.13 Million	₩-255.80 Million ≈ $-173.36K	-0.002x	-140.30%
2017-12-31	₩66.94 Billion ≈ $45.37 Million	₩-62.62 Million ≈ $-42.43K	-0.001x	+99.61%
2016-12-31	₩53.43 Billion ≈ $36.21 Million	₩-12.68 Billion ≈ $-8.59 Million	-0.237x	-105.98%
2015-12-31	₩47.70 Billion ≈ $32.33 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.115x	-147.60%
2014-12-31	₩43.94 Billion ≈ $29.77 Million	₩10.64 Billion ≈ $7.21 Million	0.242x	+140.91%
2011-12-31	₩73.88 Billion ≈ $50.07 Million	₩7.42 Billion ≈ $5.03 Million	0.100x	--

About GemVax&KAEL Co.Ltd

KQ:082270 Korea Semiconductors & Semiconductor Equipment

Market Cap

$209.84 Million

₩309.63 Billion KRW

Market Cap Rank

#16178 Global

#586 in Korea

Share Price

₩8680.00

Change (1 day)

+0.35%

52-Week Range

₩8650.00 - ₩54500.00

All Time High

₩69800.00